Oversubscribed, series B financing for Noema Pharma’s clinical stage assets has been successfully closed raising $112 million from new and existing investors.
The institute and the research/support organization will collaborate on development of novel therapies aimed at treating the central nervous system disorder.
The company plans to launch a Phase Ib/II study of its compound NVG-291 in collaboration with researchers at Northwestern University’s Shirley Ryan AbilityLab.
WIRB-Copernicus Group (WCG) has acquired eConsent technology to help clinical trial volunteers – and their families – make more informed decisions, says CEO.
Metrion Biosciences (Metrion), an ion-channel and drug discovery CRO, has joined a network of partners to evaluate the use of primary human dorsal root ganglion (hDRG) neurons in pain research.
Replikins’ genomic understanding of the Zika and Flaviviruses has led to the development of a trivalent vaccine for Zika, Dengue, and Japanese Encephalitis.
Mid-size CROs (contract research organizations) are banding together once again, this time with Chiltern on Thursday signing a purchase agreement to acquire Theorem Clinical Research.
Contract research organization INC Research reported 14.2% net service revenue growth in Q2, compared to the same quarter last year, raised future guidance and saw its stock bump up more than 10%.
Icon has boosted its Phase I translational medicine services in Manchester, UK, in preparation for what it believes will be a boom in the drug development area.
in-PharmaTechnologist presents its weekly round-up of the latest changes on the pharmaceutical career ladder, including news from Sirona, Hospira, and Biogen Idec.
in-PharmaTechnologist presents its round-up of the latest manufacturing headlines including new facilities for Aptar and Granules, and some good news for Swiss Novartis workers.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Hemispherx Biopharma, Novartis and InVivo.
Only multiple anti-counterfeiting strategies are able to beat increasingly sophisticated criminals, according to a seminar on anti-counterfeiting at the recent AAPS trade event in New Orleans.
Nose-to-brain delivery can become a reality, even for molecules with high molecular weights, but barriers relating to administration and adsorption remain, according to a panel at AAPS.
Alnylam Pharmaceuticals, Medtronic and CHDI Foundation are collaborating to advance RNAi delivered by an implantable infusion device for treating Huntingdon’s.
Orasi Medical claims CROs and pharmas can cut the cost and length of Alzheimer’s trials, and improve accuracy, by using its brain function measuring service, which is now being promoted in Japan.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Cytovance, MPI Research and UBC.
Finnish drugmaker Orion is to follow through on plans to cut its R&D workforce and shed 205 employees to sure up operations as generic pressure mounts on its leading Parkinson’s disease drugs.
Clinical laboratory services company LabCorp saw its shares slide yesterday after cutting back its sales and earnings targets for 2009 in light of the economic downturn.
Zogenix says that proceeds from a planned $86m initial public
offering (IPO) will be used to fund development of its pipeline of
needle-free medicines for pain and central nervous system
indications.
A lab on a chip method has been developed to mimic brain
chemistry and so give a greater understanding of how neurons in the
brain interact in the formation of a nervous system.
Biogen Idec is pushing forward with a therapeutic antibody that can
turn myelin producing cells back on and so could reverse the
damaging effects of multiple sclerosis (MS).
A team of scientists at Biogen Idec have unveiled preclinical data
for a potential protein therapeutic to treat Alzheimer's, a disease
normally only attacked using small molecules due to delivery
issues.
ADInstruments has launched its Neuro Amp EX to improve neurological
data collection from animals and humans during drug candidate
testing by reducing noise and improving ease of use.
Pharma company Medichem has announced it has passed a US Food and
Drug Administration (FDA) inspection without any problem for the
third consecutive time.
Evotec AG has sold its cell analysis instrument division, Evotech
Technologies, to PerkinElmer to allow it to focus more keenly on
its drug discovery pipeline and drug discovery services divisions.
Scientists have made available a powerful new tool for studying
brain development, which will help scientists discover the genetic
origins of brain cancers, which could speed development of novel
drugs to treat them.
New drugs that are based on a compound found in the body may give
renewed hope to stroke victims and sufferers of degenerative brain
diseases such as Alzheimer's as researchers are hopeful of a new
therapeutic approach.
Vasogen announced preclinical data this week, demonstrating the
ability of its lead drug candidate to modulate key signalling
pathways associated with inflammation, demonstrating therapeutic
potential in a range of neurological disorders.
US researchers have made a bold claim by announcing that after
successful laboratory experiments, growth, repair and return of
nerve cell function has been achieved. If substantiated, the
discovery is set to open up a plethora of...
Biotechnology company, Biogen has announced the identification of a
molecule that may play a key role in the repair and regeneration of
the central nervous system (CNS). The finding could lead to
potential pathways for treating multiple...
Switzerland's Siegfried Group, a specialist in active
pharmaceutical ingredients (APIs), dosage forms and
biopharmaceuticals, has boosted its position in the production of
controlled substances with the acquisition of US-based...
The first genetic disease that affects the central nervous system
has been successfully treated in an animal model, which if
successfully applied to humans, could treat an entire class of
diseases called lysosomal storage disorders....
